25 XP   0   0   10

Anteo Diagnostics Ltd
Buy, Hold or Sell?

Let's analyse Anteo Diagnostics Ltd together

PenkeI guess you are interested in Anteo Diagnostics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Anteo Diagnostics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Anteo Diagnostics Ltd

I send you an email if I find something interesting about Anteo Diagnostics Ltd.

Quick analysis of Anteo Diagnostics Ltd (30 sec.)










What can you expect buying and holding a share of Anteo Diagnostics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$-0.02
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.02
Return On Investment
-77.0%

For what price can you sell your share?

Current Price per Share
A$0.02
Expected price per share
A$0 - A$0.021
How sure are you?
50%

1. Valuation of Anteo Diagnostics Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.02

Intrinsic Value Per Share

A$-0.06 - A$-0.03

Total Value Per Share

A$-0.05 - A$-0.03

2. Growth of Anteo Diagnostics Ltd (5 min.)




Is Anteo Diagnostics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.5m$8.2m-$6.6m-419.9%

How much money is Anteo Diagnostics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$8.4m-$7.1m-$1.2m-15.3%
Net Profit Margin-3,460.1%-1,408.5%--

How much money comes from the company's main activities?

3. Financial Health of Anteo Diagnostics Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#793 / 990

Most Revenue
#635 / 990

Most Profit
#550 / 990

Most Efficient
#847 / 990

What can you expect buying and holding a share of Anteo Diagnostics Ltd? (5 min.)

Welcome investor! Anteo Diagnostics Ltd's management wants to use your money to grow the business. In return you get a share of Anteo Diagnostics Ltd.

What can you expect buying and holding a share of Anteo Diagnostics Ltd?

First you should know what it really means to hold a share of Anteo Diagnostics Ltd. And how you can make/lose money.

Speculation

The Price per Share of Anteo Diagnostics Ltd is A$0.021. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Anteo Diagnostics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Anteo Diagnostics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Anteo Diagnostics Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-16.3%0.00-16.3%0.00-13.8%0.00-9.3%0.00-8.2%
Usd Book Value Change Per Share0.00-12.8%0.00-12.8%0.00-11.3%0.00-0.4%0.00-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.006.0%0.003.0%
Usd Total Gains Per Share0.00-12.8%0.00-12.8%0.00-11.3%0.005.6%0.003.0%
Usd Price Per Share0.03-0.03-0.04-0.05-0.05-
Price to Earnings Ratio-7.80--7.80--14.97--29.91--40.71-
Price-to-Total Gains Ratio-9.89--9.89--18.32-45.70-22.30-
Price to Book Ratio41.54-41.54-12.99-21.46-23.15-
Price-to-Total Gains Ratio-9.89--9.89--18.32-45.70-22.30-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0139839
Number of shares71510
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (71510 shares)-192.5184.09
Gains per Year (71510 shares)-770.03336.35
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-770-780361-25326
20-1540-1550723-50662
30-2310-23201084-75998
40-3080-30901446-1001334
50-3850-38601807-1251670
60-4620-46302169-1512006
70-5390-54002530-1762342
80-6160-61702891-2012678
90-6930-69403253-2263014
100-7700-77103614-2513350

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%1.023.01.04.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%10.015.00.040.0%
Dividend per Share0.00.01.00.0%1.00.02.033.3%2.00.03.040.0%2.00.08.020.0%7.00.018.028.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%5.05.00.050.0%12.013.00.048.0%

Fundamentals of Anteo Diagnostics Ltd

About Anteo Diagnostics Ltd

AnteoTech Limited develops, commercializes, manufactures, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. Its products include AnteoBind ready-to-use applications to streamline and enhance the conjugation process; and AnteoX, an additive that reinforces battery binders helping maximize performance of silicon containing anodes. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.

Fundamental data was last updated by Penke on 2024-06-04 07:03:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Anteo Diagnostics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Anteo Diagnostics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare¬†Anteo Diagnostics Ltd to the¬†Biotechnology industry mean.
  • A Net Profit Margin of -3,460.1%¬†means that¬†$-34.60 for each $1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Anteo Diagnostics Ltd:

  • The MRQ is -3,460.1%. The company is making a huge loss. -2
  • The TTM is -3,460.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-3,460.1%TTM-3,460.1%0.0%
TTM-3,460.1%YOY-1,408.5%-2,051.6%
TTM-3,460.1%5Y-1,559.6%-1,900.4%
5Y-1,559.6%10Y-1,042.8%-516.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,460.1%-168.6%-3,291.5%
TTM-3,460.1%-223.2%-3,236.9%
YOY-1,408.5%-242.8%-1,165.7%
5Y-1,559.6%-392.9%-1,166.7%
10Y-1,042.8%-503.2%-539.6%
1.1.2. Return on Assets

Shows how efficient Anteo Diagnostics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Anteo Diagnostics Ltd to the¬†Biotechnology industry mean.
  • -236.0% Return on Assets means that¬†Anteo Diagnostics Ltd generated¬†$-2.36 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Anteo Diagnostics Ltd:

  • The MRQ is -236.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -236.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-236.0%TTM-236.0%0.0%
TTM-236.0%YOY-70.2%-165.8%
TTM-236.0%5Y-96.3%-139.7%
5Y-96.3%10Y-68.9%-27.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-236.0%-11.6%-224.4%
TTM-236.0%-11.5%-224.5%
YOY-70.2%-10.9%-59.3%
5Y-96.3%-12.9%-83.4%
10Y-68.9%-14.2%-54.7%
1.1.3. Return on Equity

Shows how efficient Anteo Diagnostics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Anteo Diagnostics Ltd to the¬†Biotechnology industry mean.
  • -532.5% Return on Equity means Anteo Diagnostics Ltd generated $-5.32¬†for each¬†$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Anteo Diagnostics Ltd:

  • The MRQ is -532.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -532.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-532.5%TTM-532.5%0.0%
TTM-532.5%YOY-86.7%-445.7%
TTM-532.5%5Y-164.8%-367.7%
5Y-164.8%10Y-117.2%-47.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-532.5%-13.8%-518.7%
TTM-532.5%-14.6%-517.9%
YOY-86.7%-13.6%-73.1%
5Y-164.8%-18.1%-146.7%
10Y-117.2%-19.0%-98.2%

1.2. Operating Efficiency of Anteo Diagnostics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Anteo Diagnostics Ltd is operating .

  • Measures how much profit Anteo Diagnostics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Anteo Diagnostics Ltd to the¬†Biotechnology industry mean.
  • An Operating Margin of -3,650.7%¬†means the company generated $-36.51 ¬†for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Anteo Diagnostics Ltd:

  • The MRQ is -3,650.7%. The company is operating very inefficient. -2
  • The TTM is -3,650.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-3,650.7%TTM-3,650.7%0.0%
TTM-3,650.7%YOY-1,673.0%-1,977.7%
TTM-3,650.7%5Y-1,750.3%-1,900.4%
5Y-1,750.3%10Y-1,151.9%-598.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,650.7%-340.8%-3,309.9%
TTM-3,650.7%-230.7%-3,420.0%
YOY-1,673.0%-258.7%-1,414.3%
5Y-1,750.3%-384.5%-1,365.8%
10Y-1,151.9%-489.8%-662.1%
1.2.2. Operating Ratio

Measures how efficient Anteo Diagnostics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Biotechnology industry mean).
  • An Operation Ratio of 34.78 means that the operating costs are $34.78 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 34.777. The company is inefficient in keeping operating costs low. -1
  • The TTM is 34.777. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ34.777TTM34.7770.000
TTM34.777YOY16.931+17.846
TTM34.7775Y16.772+18.005
5Y16.77210Y11.729+5.043
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ34.7773.052+31.725
TTM34.7773.291+31.486
YOY16.9313.562+13.369
5Y16.7724.839+11.933
10Y11.7296.206+5.523

1.3. Liquidity of Anteo Diagnostics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Anteo Diagnostics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Biotechnology industry mean).
  • A Current Ratio of 1.74¬†means the company has $1.74 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 1.741. The company is able to pay all its short-term debts. +1
  • The TTM is 1.741. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.741TTM1.7410.000
TTM1.741YOY6.700-4.959
TTM1.7415Y9.357-7.615
5Y9.35710Y8.251+1.106
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7413.767-2.026
TTM1.7414.032-2.291
YOY6.7004.958+1.742
5Y9.3575.974+3.383
10Y8.2516.338+1.913
1.3.2. Quick Ratio

Measures if Anteo Diagnostics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Anteo Diagnostics Ltd to the¬†Biotechnology industry mean.
  • A Quick Ratio of 1.62¬†means the company can pay off $1.62 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 1.617. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.617. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.617TTM1.6170.000
TTM1.617YOY6.543-4.926
TTM1.6175Y9.143-7.526
5Y9.14310Y7.746+1.397
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6173.141-1.524
TTM1.6173.604-1.987
YOY6.5434.808+1.735
5Y9.1435.825+3.318
10Y7.7466.378+1.368

1.4. Solvency of Anteo Diagnostics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Anteo Diagnostics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Anteo Diagnostics Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.56¬†means that Anteo Diagnostics Ltd assets are¬†financed with 55.7% credit (debt) and the remaining percentage (100% - 55.7%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 0.557. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.557. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.557TTM0.5570.000
TTM0.557YOY0.191+0.366
TTM0.5575Y0.229+0.328
5Y0.22910Y0.302-0.073
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5570.336+0.221
TTM0.5570.347+0.210
YOY0.1910.289-0.098
5Y0.2290.369-0.140
10Y0.3020.381-0.079
1.4.2. Debt to Equity Ratio

Measures if Anteo Diagnostics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Anteo Diagnostics Ltd to the¬†Biotechnology industry mean.
  • A Debt to Equity ratio of 125.6% means that company has $1.26 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 1.256. The company is able to pay all its debts with equity. +1
  • The TTM is 1.256. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.256TTM1.2560.000
TTM1.256YOY0.235+1.021
TTM1.2565Y0.391+0.865
5Y0.39110Y1.052-0.660
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2560.372+0.884
TTM1.2560.419+0.837
YOY0.2350.372-0.137
5Y0.3910.446-0.055
10Y1.0520.476+0.576

2. Market Valuation of Anteo Diagnostics Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Anteo Diagnostics Ltd generates.

  • Above 15 is considered overpriced but¬†always compare¬†Anteo Diagnostics Ltd to the¬†Biotechnology industry mean.
  • A PE ratio of -7.80 means the investor is paying $-7.80¬†for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Anteo Diagnostics Ltd:

  • The EOD is -4.096. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.802. Based on the earnings, the company is expensive. -2
  • The TTM is -7.802. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.096MRQ-7.802+3.706
MRQ-7.802TTM-7.8020.000
TTM-7.802YOY-14.971+7.169
TTM-7.8025Y-29.912+22.110
5Y-29.91210Y-40.706+10.794
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.096-2.241-1.855
MRQ-7.802-2.903-4.899
TTM-7.802-2.857-4.945
YOY-14.971-3.454-11.517
5Y-29.912-6.141-23.771
10Y-40.706-6.401-34.305
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Anteo Diagnostics Ltd:

  • The EOD is -5.908. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -11.253. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -11.253. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.908MRQ-11.253+5.345
MRQ-11.253TTM-11.2530.000
TTM-11.253YOY-13.630+2.377
TTM-11.2535Y-37.621+26.368
5Y-37.62110Y-50.707+13.086
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.908-2.850-3.058
MRQ-11.253-3.599-7.654
TTM-11.253-3.642-7.611
YOY-13.630-4.800-8.830
5Y-37.621-7.853-29.768
10Y-50.707-8.420-42.287
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Anteo Diagnostics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Biotechnology industry mean).
  • A PB ratio of 41.54 means the investor is paying $41.54¬†for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Anteo Diagnostics Ltd:

  • The EOD is 21.810. Based on the equity, the company is expensive. -2
  • The MRQ is 41.543. Based on the equity, the company is expensive. -2
  • The TTM is 41.543. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD21.810MRQ41.543-19.733
MRQ41.543TTM41.5430.000
TTM41.543YOY12.986+28.558
TTM41.5435Y21.460+20.084
5Y21.46010Y23.148-1.688
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD21.8101.852+19.958
MRQ41.5432.209+39.334
TTM41.5432.225+39.318
YOY12.9862.441+10.545
5Y21.4603.709+17.751
10Y23.1484.178+18.970
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Anteo Diagnostics Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Anteo Diagnostics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.004-0.0040%-0.004-12%0.000-97%0.000-100%
Book Value Per Share--0.0010.0010%0.005-81%0.004-73%0.003-71%
Current Ratio--1.7411.7410%6.700-74%9.357-81%8.251-79%
Debt To Asset Ratio--0.5570.5570%0.191+192%0.229+143%0.302+84%
Debt To Equity Ratio--1.2561.2560%0.235+434%0.391+221%1.052+19%
Dividend Per Share----0%-0%0.002-100%0.001-100%
Eps---0.005-0.0050%-0.004-15%-0.003-43%-0.003-49%
Free Cash Flow Per Share---0.004-0.0040%-0.005+34%-0.002-30%-0.002-43%
Free Cash Flow To Equity Per Share---0.003-0.0030%-0.005+53%0.000-98%-0.001-82%
Gross Profit Margin--1.1381.1380%1.185-4%1.136+0%1.199-5%
Intrinsic Value_10Y_max---0.029--------
Intrinsic Value_10Y_min---0.055--------
Intrinsic Value_1Y_max---0.002--------
Intrinsic Value_1Y_min---0.004--------
Intrinsic Value_3Y_max---0.007--------
Intrinsic Value_3Y_min---0.013--------
Intrinsic Value_5Y_max---0.013--------
Intrinsic Value_5Y_min---0.024--------
Market Cap51834091.008-90%98731601.92098731601.9200%160438853.120-38%194007597.773-49%180654148.613-45%
Net Profit Margin---34.601-34.6010%-14.085-59%-15.596-55%-10.428-70%
Operating Margin---36.507-36.5070%-16.730-54%-17.503-52%-11.519-68%
Operating Ratio--34.77734.7770%16.931+105%16.772+107%11.729+197%
Pb Ratio21.810-90%41.54341.5430%12.986+220%21.460+94%23.148+79%
Pe Ratio-4.096+48%-7.802-7.8020%-14.971+92%-29.912+283%-40.706+422%
Price Per Share0.021-90%0.0400.0400%0.065-38%0.079-49%0.073-45%
Price To Free Cash Flow Ratio-5.908+48%-11.253-11.2530%-13.630+21%-37.621+234%-50.707+351%
Price To Total Gains Ratio-5.195+48%-9.894-9.8940%-18.318+85%45.704-122%22.298-144%
Quick Ratio--1.6171.6170%6.543-75%9.143-82%7.746-79%
Return On Assets---2.360-2.3600%-0.702-70%-0.963-59%-0.689-71%
Return On Equity---5.325-5.3250%-0.867-84%-1.648-69%-1.172-78%
Total Gains Per Share---0.004-0.0040%-0.004-12%0.002-329%0.001-533%
Usd Book Value--1582571.2811582571.2810%8227337.003-81%5765362.733-73%5373648.789-71%
Usd Book Value Change Per Share---0.003-0.0030%-0.002-12%0.000-97%0.000-100%
Usd Book Value Per Share--0.0010.0010%0.003-81%0.002-73%0.002-71%
Usd Dividend Per Share----0%-0%0.001-100%0.001-100%
Usd Eps---0.003-0.0030%-0.003-15%-0.002-43%-0.002-49%
Usd Free Cash Flow---5842608.598-5842608.5980%-7838541.299+34%-4062235.051-30%-3345152.379-43%
Usd Free Cash Flow Per Share---0.002-0.0020%-0.003+34%-0.002-30%-0.001-43%
Usd Free Cash Flow To Equity Per Share---0.002-0.0020%-0.003+53%0.000-98%0.000-82%
Usd Market Cap34516321.202-90%65745373.71965745373.7190%106836232.293-38%129189659.357-49%120297597.561-45%
Usd Price Per Share0.014-90%0.0270.0270%0.043-38%0.052-49%0.049-45%
Usd Profit---8426469.070-8426469.0700%-7136322.447-15%-4795818.592-43%-3999476.440-53%
Usd Revenue--243535.612243535.6120%506666.663-52%346318.875-30%614154.642-60%
Usd Total Gains Per Share---0.003-0.0030%-0.002-12%0.001-329%0.001-533%
 EOD+3 -5MRQTTM+0 -0YOY+7 -275Y+2 -3410Y+1 -35

4.2. Fundamental Score

Let's check the fundamental score of Anteo Diagnostics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.096
Price to Book Ratio (EOD)Between0-121.810
Net Profit Margin (MRQ)Greater than0-34.601
Operating Margin (MRQ)Greater than0-36.507
Quick Ratio (MRQ)Greater than11.617
Current Ratio (MRQ)Greater than11.741
Debt to Asset Ratio (MRQ)Less than10.557
Debt to Equity Ratio (MRQ)Less than11.256
Return on Equity (MRQ)Greater than0.15-5.325
Return on Assets (MRQ)Greater than0.05-2.360
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Anteo Diagnostics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.834
Ma 20Greater thanMa 500.023
Ma 50Greater thanMa 1000.023
Ma 100Greater thanMa 2000.028
OpenGreater thanClose0.021
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Total Other Income Expense Net 12-56112118-7147-2,550-2,503



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets5,362
Total Liabilities2,986
Total Stockholder Equity2,377
 As reported
Total Liabilities 2,986
Total Stockholder Equity+ 2,377
Total Assets = 5,362

Assets

Total Assets5,362
Total Current Assets3,142
Long-term Assets2,220
Total Current Assets
Cash And Cash Equivalents 2,720
Net Receivables 198
Other Current Assets 225
Total Current Assets  (as reported)3,142
Total Current Assets  (calculated)3,142
+/-0
Long-term Assets
Property Plant Equipment 2,220
Long-term Assets  (as reported)2,220
Long-term Assets  (calculated)2,220
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,804
Long-term Liabilities1,181
Total Stockholder Equity2,377
Total Current Liabilities
Short-term Debt 648
Accounts payable 533
Other Current Liabilities 624
Total Current Liabilities  (as reported)1,804
Total Current Liabilities  (calculated)1,804
+/-0
Long-term Liabilities
Long term Debt Total 659
Other Liabilities 523
Long-term Liabilities  (as reported)1,181
Long-term Liabilities  (calculated)1,181
+/- 0
Total Stockholder Equity
Common Stock89,302
Retained Earnings -91,016
Accumulated Other Comprehensive Income 4,091
Other Stockholders Equity 0
Total Stockholder Equity (as reported)2,377
Total Stockholder Equity (calculated)2,377
+/-0
Other
Capital Stock89,302
Cash and Short Term Investments 2,720
Common Stock Shares Outstanding 2,002,901
Current Deferred Revenue-648
Liabilities and Stockholders Equity 5,362
Net Debt -1,414
Net Invested Capital 2,377
Net Tangible Assets 2,377
Net Working Capital 1,338
Property Plant and Equipment Gross 5,502
Short Long Term Debt Total 1,306



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-30
> Total Assets 
7,865
7,933
11,527
7,971
5,037
3,435
732
1,909
1,959
3,472
1,332
1,723
7,285
5,211
3,275
7,667
6,005
52,528
45,814
4,470
4,768
3,909
23,675
15,264
5,362
5,36215,26423,6753,9094,7684,47045,81452,5286,0057,6673,2755,2117,2851,7231,3323,4721,9591,9097323,4355,0377,97111,5277,9337,865
   > Total Current Assets 
6,313
5,868
6,470
5,172
3,317
2,567
542
1,428
1,483
3,260
1,031
1,481
7,003
4,929
3,024
7,314
5,469
16,343
45,433
4,191
4,456
3,378
21,789
10,826
3,142
3,14210,82621,7893,3784,4564,19145,43316,3435,4697,3143,0244,9297,0031,4811,0313,2601,4831,4285422,5673,3175,1726,4705,8686,313
       Cash And Cash Equivalents 
6,310
5,601
5,568
3,764
1,247
422
297
1,422
1,281
3,121
953
1,426
6,864
4,883
2,621
7,071
5,174
3,760
955
3,329
4,276
3,215
21,392
10,103
2,720
2,72010,10321,3923,2154,2763,3299553,7605,1747,0712,6214,8836,8641,4269533,1211,2811,4222974221,2473,7645,5685,6016,310
       Short-term Investments 
0
0
0
5
6
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0000000000010000000065000
       Net Receivables 
0
46
92
514
870
624
1
128
173
138
76
53
137
43
402
113
111
6,594
107
4
7
73
242
469
198
19846924273741076,594111113402431375376138173128162487051492460
       Other Current Assets 
3
44
153
117
157
78
9
6
28
1
2
2
2
1
2
130
184
919
44,372
859
173
91
155
254
225
2252541559117385944,372919184130212221286978157117153443
   > Long-term Assets 
1,553
2,064
5,058
2,799
1,720
868
190
481
476
212
302
242
282
283
251
353
537
36,185
381
279
312
531
1,886
4,438
2,220
2,2204,4381,88653131227938136,1855373532512832822423022124764811908681,7202,7995,0582,0641,553
       Property Plant Equipment 
1,352
292
4,439
2,277
1,273
737
123
481
476
212
302
242
282
283
251
353
537
22,919
381
279
312
531
1,886
4,015
2,220
2,2204,0151,88653131227938122,9195373532512832822423022124764811237371,2732,2774,4392921,352
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,912
0
0
0
0
0
0
0
00000009,91200000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
8
0
0
0
0
0
0
0000008800000000000000000
       Intangible Assets 
201
288
383
456
447
131
67
0
0
0
0
0
0
0
0
0
0
3,347
13,240
0
0
0
0
0
0
00000013,2403,347000000000067131447456383288201
       Other Assets 
0
1,484
3,710
1,269
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000001,2693,7101,4840
> Total Liabilities 
11
618
1,328
1,598
1,582
1,327
205
317
409
462
300
329
394
439
500
566
692
38,641
38,711
468
533
700
2,561
2,909
2,986
2,9862,9092,56170053346838,71138,6416925665004393943293004624093172051,3271,5821,5981,32861811
   > Total Current Liabilities 
11
593
1,156
1,435
1,443
1,272
205
317
409
462
300
329
394
439
500
483
598
17,159
38,675
450
347
623
1,084
1,616
1,804
1,8041,6161,08462334745038,67517,1595984835004393943293004624093172051,2721,4431,4351,15659311
       Short-term Debt 
0
11
48
190
91
115
37
0
0
0
0
0
0
0
0
0
0
269
226
0
135
135
277
258
648
64825827713513502262690000000000371159119048110
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,266
834
0
0
0
0
0
0
00000083411,26600000000000000000
       Accounts payable 
11
556
1,002
1,109
1,143
960
155
245
331
412
242
204
48
90
144
165
226
3,118
367
153
130
61
390
704
533
533704390611301533673,11822616514490482042424123312451559601,1431,1091,00255611
       Other Current Liabilities 
0
37
433
1,084
653
528
110
71
77
50
58
124
346
349
355
318
372
12,571
38,081
297
218
427
417
655
624
62465541742721829738,08112,571372318355349346124585077711105286531,084433370
   > Long-term Liabilities 
0
25
172
164
138
55
0
0
0
0
0
0
0
0
0
83
95
23,546
36
18
185
77
1,477
1,293
1,181
1,1811,2931,47777185183623,546958300000000055138164172250
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,089
0
0
0
0
1,005
776
659
6597761,005000015,08900000000000000000
       Other Liabilities 
0
0
0
7
0
32
0
0
0
0
0
0
0
0
0
83
65
10,973
36
18
185
77
472
517
523
52351747277185183610,97365830000000003207000
> Total Stockholder Equity
7,854
7,315
10,199
6,373
3,456
2,108
527
1,592
1,550
3,010
1,033
1,394
6,891
4,773
2,776
7,101
5,313
13,887
7,103
4,002
4,235
3,209
21,114
12,355
2,377
2,37712,35521,1143,2094,2354,0027,10313,8875,3137,1012,7764,7736,8911,3941,0333,0101,5501,5925272,1083,4566,37310,1997,3157,854
   Common Stock
7,873
7,882
12,168
17,506
17,535
19,063
19,126
16,746
18,359
21,536
21,536
24,153
31,859
32,121
31,969
38,658
41,098
55,100
58,738
59,062
62,421
64,292
86,209
87,454
89,302
89,30287,45486,20964,29262,42159,06258,73855,10041,09838,65831,96932,12131,85924,15321,53621,53618,35916,74619,12619,06317,53517,50612,1687,8827,873
   Retained Earnings -91,016-78,362-67,645-61,429-58,356-55,847-52,396-43,765-37,009-32,012-29,522-27,348-24,968-22,744-20,504-18,526-16,809-15,154-18,599-16,955-14,080-11,133-1,969-568-19
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
0
71
188
358
708
1,022
747
1,129
-212
1,322
-70
1,397
1,404
1,512
1,808
2,039
257
2,043
3,195
0
2,331
-2,862
-18,564
-9,093
0
0-9,093-18,564-2,8622,33103,1952,0432572,0391,8081,5121,4041,397-701,322-2121,1297471,022708358188710



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.